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Febrile Seizure (FC) is one of the most common transient neurologic disorders in 
infants and childhood. Its prevalence is about 2-5% and the mean age at onset is 3 
month to 5 yr old (1). Even the prognosis is good for the most patients, but seizures 
Abstract 
Objective
Febrile seizure is the most common neurologic problem in children between 
3 months to 5 years old. Two to five percent of children aged less than five yr 
old will experience it at least one time. This type of seizure is age dependent 
and its recurrence rate is about 33% overalls and 50% in children less than one 
yr old.
The prophylactic treatment is still controversial, so we conducted a randomized 
controlled clinical trial to find out the effectiveness of continuous phenobarbital 
versus intermittent diazepam for febrile seizure.
Materials & Methods
This clinical trial was conducted in the Department of Pediatric Neurology, 
Babol University of Medical Sciences, Babol, Iran between March 2008 and 
October 2010. All children from 6 month to 5 yr old referred to Amirkola 
Children’s Hospital, Babol, Iran were enrolled in the study. Children with 
febrile seizure that had indication for prophylaxis but did not receive any 
prophylaxis previously were enrolled in the study. For prophylactic anti 
convulsion therapy, patients were divided randomly in two groups. One 
group received continuous phenobarbital and another treated with intermittent 
diazepam whenever the children experienced an episode of febrile illness for 
up to one year after their last convulsion.
Results
Of all 145 studied cases, the recurrent rate in children under prophylaxis with 
diazepam was 11/71 and in phenobarbital group was 17/74. There was no 
significant difference in the recurrence rate in both groups. 
Conclusion
There was no significant difference in the effectiveness of phenobarbital and 
diazepam in prevention of recurrent in febrile seizure and we think that in 
respect of lower complication rate in diazepam administration, it cloud be 
better choice than phenobarbital.
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to 5 yr old with recurrent simple FC(≥ 3 episode) or 
complex FC that did not receive any anticonvulsive 
drug ,were enrolled into the study. Simple FC were 
defined as brief (< 15 minutes), generalized seizure in 
association with fever and only once during a 24-hour 
period. Childe with history of neonatal seizure, seizure 
without fever, chronic disease related electrolytes 
imbalance and history of anticonvulsive consumption, 
were excluded. 
The study was approved by the regional Ethics 
Committee of Babol University of Medical Sciences.
After getting informed consent of child parents, all 
of them randomly were divided in tow prophylaxis 
groups. 
One group received oral phenobarbital (Tab 15 and 60 
mg), 3-5 mg/kg/day in tow divided doses for at least 
one year and another group was recommended to use 
oral diazepam 0.33 mg/kg/TDS during febrile illness 
for two days without antipyretics consumption. 
We recommended that the child should be admitted to 
hospital if new convulsions occurred. Basic data on the 
mother’s pregnancy, the child’s birth, neonatal period, 
sex, age, previous febrile convulsions with detailed 
description of first convulsion, and epilepsy in parents 
or siblings were obtained from medical document and 
parents. All cases were fallowed regularly up to one 
year after their convulsion. In each monthly call, parents 
were questioned about occurrence of fever, new febrile 
convulsions, compliance with instructions, drug related 
side effects, and assesses the child’s clinical progress, 
including possible side effects of medication.
In case of unable to follow the patient, or other 
diagnoses achieved, he/she was excluded. The main 
outcome was report of febrile seizures by the parents. 
Data were analyzed using the chi-squared test or 
Fisher’s exact test using the SPSS version 21 (Chicago, 
IL, USA).
P less than 0.05 were considered significant.
Results
Of all 154 studied patients, nine patients excluded 
because of the aforementioned causes. Out of the 
remaining 145 patients, 71 were in the diazepam and 
74 in the phenobarbital group. The mean age of them 
was 22.61±9.11 and 20.59±7.93 months respectively 
are upsetting to the children and parents. Prevention of 
the next seizures is important for prevention of brain 
hypoxic damage and sudden fall related injuries (2, 3). 
Fortunately, in most cases, there is no need to treatment 
but in some cases with high risk for recurrence 
prophylaxis must be considered. 
The overall rate of recurrence after the first episode 
is about 30%-37% but in child less than 1 year old, it 
could be about 50% (4).
Some recurrence risk factors include age less than one 
yr old, the history of febrile seizure in fist – degree 
relatives of seizures occur at temperatures less than 
39°C and when there is low Interval between fever and 
seizure (5). In child with one episode of recurrence, 
the risk of subsequent recurrence increases and 9-17% 
of them will experience more than 3 times recurrence. 
Three quarters of it occurs within the first year after 
seizure (5). 
Intermittent prophylaxis with oral diazepam during 
the first 3 days of febrile illnesses is associated with 
less complication such as lethargy and ataxia (6) but 
permanent prophylaxis with oral phenobarbital may 
be associated with complications like behavioral 
disturbances, irritability, hyperactivity and decreased 
of cognitive function (7). Use of rectal diazepam during 
an episode of seizure is another method of prophylaxis 
not often considered because of its failure to prevent 
the onset of seizure and its age related limitation. It is 
used to prevent seizure in 3 to 5 yr-old children and 
thus prevent prolongation of seizures and its recurrence 
until next 12 hours (6, 8).
To evaluate the efficacy of different anticonvulsive 
regimes for preventing febrile seizures, many 
randomized clinical trials muse be done. In this study, 
we conducted a single blind, randomized clinical trial 
to compare effectiveness of intermittent oral diazepam 
versus continuous phenobarbital in  children with 
febrile convolution.
Materials & Methods
This single blind randomized clinical trial, registered 
as RCT of code No. CT2015080223393N2, was done 
in the Department of Pediatric Neurology, Babol 
University of Medical Sciences, Babol, Iran between 
March 2008 and October 2010. All children 6 months 
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(P =0.158).
There was no significant difference between the mean 
age of cases in both groups and according to the Fig 1, 
the age of patient followed normal distribution curve. 
Table 1 shows the demographic data of patient in both 
groups and according to Fishers Exact Test result, 
there was no significant difference between the base 
line variable in both groups. In one year’s fallow up 
of patients, we had recurrence in 11 (15.5%) cases of 
diazepam group and in 17 cases (23%) of phenobarbital 
group. There was no significant difference between the 
recurrence rate in both groups (P=0.296).
Side effects of phenobarbital like hyperkinesia, 
irritability, and restlessness were observed in some 
patients but diazepam related side effects except 
sedation were not seen.
Table1. Clinical Data Phenobarbital versus Diazepam
Group Phenobarbital n (%) Diazepam n (%) Fishers Exact Test
Male 46 (62.2) 41(57.7)
0.614
Female 28 (37.8) 30(42.3)
Recurrent Febrile Seizure 50 (67.6) 50(70.4)
0.724
Complex Febrile Seizure 24 (32.4) 21(29.6)
Discussion
We did not find any significant difference of two 
studied prophylaxis protocols but the recurrence rate 
by diazepam was less than phenobarbital (15.5% vs. 
23%).
Most previous studies have compared two drugs with 
placebo and clinical trials comparing these together are 
fewer.
In Italy, the rate of febrile seizure recurrence with oral 
diazepam was about 11.1% compared to the 30.7% 
recurrence rate in those who did not receive any 
treatment, was substantially reduced. Lack of timely 
detection of fever by parents was one of the diazepam 
administration problems in addition to ataxia and 
lethargy as side effects (9). Rose and colleagues (11) 
conducted a study on clobazam and the ataxia rate was 
less than diazepam. 
In a study, recurrent febrile seizure risk, significantly 
reduced with intermittent oral diazepam versus placebo 
or phenobarbital versus placebo (10). However, parents 
and families should be supported with adequate 
contact details of medical services and information on 
recurrence, first aid management and, most importantly, 
the benign nature of the phenomenon (10). Efficacy 
of diazepam in preventing febrile seizure compared 
with placebo is obvious, but it was not statistically 
significant (2, 3).
In conclusion, Diazepam is a safe and quickly 
absorbed anticonvulsant that its peak serum level in 
oral consumption, reach more rapidly in children and 
we think in respect of the well-known side effects of 
phenobarbital, it can be a good choice for prophylaxis 
of febrile seizure.
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Fig 1. The age of patient follows normal distribution curve
Age of patients by month
The frequency of seizure 
